Related Experiment Videos
Bovine cyclic endometrium contains high-affinity luteinizing hormone/human chorionic gonadotropin binding sites
S Freidman1, M Gurevich, M Shemesh
1Department of Hormone Research, Koret School of Veterinary Medicine Hebrew University, Bet Dagan, Israel.
Biology of Reproduction
|May 1, 1995
Summary
Researchers identified luteinizing hormone/human chorionic gonadotropin (LH/hCG) binding sites in bovine endometrium, with levels varying during the estrous cycle. These sites were most abundant during specific phases, suggesting a role in reproductive processes.
Area of Science:
- Reproductive Biology
- Endocrinology
- Molecular Endocrinology
Background:
- High-affinity luteinizing hormone/human chorionic gonadotropin (LH/hCG) binding sites are known in several species' uteri.
- Understanding these sites in cattle is crucial for reproductive research.
Purpose of the Study:
- To characterize LH/hCG binding sites in bovine endometrium.
- To determine the presence and concentration of these sites throughout the bovine estrous cycle.
- To compare endometrial LH/hCG binding with that of luteal cells.
Main Methods:
- Radioreceptor assays using endometrial membrane homogenates.
- Specificity testing with various hormones (FSH, prolactin, eCG).
- Western blot analysis for cyclooxygenase (COX) expression.
Main Results:
- LH/hCG binding sites were found in bovine endometrium, with specificity for hCG and some cross-reactivity with eCG.
- Receptor concentrations varied during the estrous cycle, with higher levels on Days 2-4 and 15-17.
- Endometrial binding capacity was lower than that of luteal cells, but affinity constants were similar.
- Cyclooxygenase (COX) expression was strongest at Days 15-17 of the estrous cycle.
Conclusions:
- Bovine endometrium possesses specific LH/hCG binding sites whose concentration fluctuates during the estrous cycle.
- These endometrial sites may play a role in bovine reproduction, distinct from luteal cell binding.
- The temporal expression of COX aligns with periods of high endometrial LH/hCG receptor concentration.